
SmartNuclide
智核生物
SmartNuclide
Biotech/Healthcare
Founded in 2015, Suzhou SmartNuclide Biopharmaceutical Technology Co., Ltd. is a new drug R&D company dedicated to tumor diagnosis and treatment using recombinant protein radiopharmaceuticals.
Latest round: Series D (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-09-14
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.